Working till I drop over dead thanks AAPL

AAPL missed earnings est. but just a little. I'll sell the three calls one at a time, one in Dec, Jan and Feb, hoping I can cut the loss to 40% which is still a big loss. AAPL closed down $5.54 at $604 alot of volume 36.7 million shares. The three month avg. volume is 16.7 million shares. ................................................... .............................................................................................................................................................................. Geron up 3 cents at $1.30 volume a little better at 1.2 million shares. Dec, Geron will tell us how the last 4 Phase two trials are going. If there is any run up I'm sell 5 thousand shares. Geron as been batting zero I can't lose more money on this company. .............................................................................................................................................................................. ACTC down a little at 0.0701 on 4.4 million shares. Need news or we go lower........... .............................................................................................................................................................................. Good luck in this rigged casino,

AAPPL, ACTC and Geron all up

AAPL was up $3.47 to close at $616.83 on 19.8 million shares. Thursday is the make or break day for my calls. Need blow out earnings and a $50+ run up....................... .....................................................................................................................................................................................................................................................................ACTC up a little at 0.0710. Only 3.9 million shares the three month avg. volume is 5.7 million shares. With no news we go lower. May buy a little under 7 cents............... ............................................................................................................................................................................................................................................................................................................................................................ Geron no news on the deal, I'm betting Chip will tell all Oct 30th at 4:30PM it will be webcast, earninngs call. Geron closed at $1.34 up 2 cents volume was only 405,164 shares. There's no interest in this company. Need good news on the last 4 Phase two trials. If no good news we go under $1.....................................................................................May add BTX to my holdings but only 100 shares................................... .......................................................................................Good luck in this rigged casino,

AAPL down big, ACTC and Geron down

AAPL's iPod mini looks great but the $329 price may be to much, so the market thinks. I'm thinking they will sell 10 million+. Down $20.67 to close at $613.36, volume was 25.1 million shares. The three month avg. volume 16.3 million shares. ..................................................................................................................................................................................................................................................................................ACTC down a little at 0.0702, holding 7 cents but not for long without good news. ..................................................................................................................................................................................................................................................................................Geron down a little at $1.32 on 768,621 shares. No word on the BioTime deal..................................................................................................................................................................................................................................................................Good luck in this rigged casino,

Tom Okarma working for BTX was working for Geron

Dr West is CEO of BioTime and was the founder of Geron. Tom Okarma was hired by Dr. West who also worked at Geron and was a leader in the embryonic movement. Was Geron sell [more like give it to BioTime] it to Dr. West. Maybe. If I remember what I read GE has the right to review any deal and make a deal with Geron. Geron closed down 0.055 cents at $1.38. The volume was low only 452,103 shares ..................................................................................................................................... ..................................................................................................................................................................................................................................................................... ACTC closed down a little at 0.0715. I think we go under 6 maybe by Dec................ ..............................................................................................................................................................................AAPL up big to close at $634.03, need $40 more for my calls. The iPod mini Tue. and earnings Thur.......................................................................... ..............................................................................................................................................................................Good luck in this rigged casino,

ACTC Clinical Trial Advances

Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in its European clinical trial for Stargardt’s Macular Dystrophy (SMD). The patient was injected with 100,000 human embryonic stem cell-derived retinal pigment epithelial (RPE) cells, as compared with 50,000 cells in the three patients comprising the first cohort. The outpatient transplantation surgery was performed successfully and the patient is recovering uneventfully. “Our progress continues in our European clinical trial and both our trials in the U.S., as seen most recently with last week’s announcement of treatment of the second patient in the second patient cohort of our U.S. trial for SMD,” said Gary Rabin, chairman and CEO of ACT. “As I mentioned last week, we have mapped out the series of patients to complete the second cohort of both our trials for SMD, as well as for our trial for dry age-related macular degeneration (dry AMD), pending DSMB review, and we anticipate generating patient data at a faster pace.” Initiated in January of this year, the Phase I/II trial is designed to determine the safety and tolerability of hESC-derived RPE cells following sub-retinal transplantation in patients with SMD at 12 months, the study’s primary endpoint. It will involve a total of 12 patients, with cohorts of three patients each in an ascending dosage format. The company is concurrently conducting another trial for SMD and one for dry AMD, both in the U.S. “We are very gratified to be initiating the first treatment of the second patient cohort in our European clinical trial, having just started it this year,” commented Robert Lanza, M.D., ACT’s chief scientific officer. “Our two U.S. trials also continue to move steadily forward.” Further information about patient eligibility for ACT’s SMD study and the concurrent studies in the U.S. and Europe (for dry age-related macular degeneration and SMD, respectively) are available at www.clinicaltrials.gov, with the following Identifiers: NCT01469832 (E.U. SMD), NCT01345006 (U.S. SMD), and NCT01344993 (dry AMD). About Stargardt’s Disease Stargardt’s disease or Stargardt’s Macular Dystrophy is a genetic disease that causes progressive vision loss, usually starting in children between 10 to 20 years of age. Eventually, blindness results from photoreceptor loss associated with degeneration in the pigmented layer of the retina, called the retinal pigment epithelium, which is the site of damage that the company believes the hESC-derived RPE may be able to target for repair after administration........................................................ ..................................................................................................................................................................................................................................................................... Good news, I hope the results are great. This would be great news for all the stem cell companies and the science....................................................... ..................................................................................... Good luck in this rigged casino,

It's a Small World for Geron

I was reading about BioTime and found Dr. Michael West is CEO of BioTime. Dr. West was also the founder of Geron 20+ years ago. He left Geron a few years back. Now Dr. West wants to buy his baby back, nice. Also BioTime uses ACTCellerate technology, yea ACTC what a small world. I'm thinking there's a game being played here and the shareholders are not in on it...................................................................... .............................................................................................................................................................................. Good luck in this rigged casino,

Geron, ACTC, AAPL all down

AAPL is killing me, closed at $609.84. I need blowout earnings Oct 25th, a $65 run up for my calls to make money. ....................................................................................... ACTC down again at 0.0733. With no news we go lower. ...................................................................................... Geron closed at $1.44 down we go. The BXT offer is better than nothing, but it's close to nothing. I'll vote for it.......................................................... ....................................................................................... Good luck in this rigged casino,